THYROID DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE

It is known that patients with chronic kidney disease (CKD) often have hypothyroidism. In patients with CKD, iodine excretion in the urine is disrupted. The high content of iodine in the thyroid gland and tissues leads to a disruption in the synthesis and peripheral metabolism of thyroid hormones. In hypothyroidism, there is a disruption of sodium and water reabsorption in the proximal tubule, the volume of the filtrate increases, the volume of the tubular apparatus overloads, and the eGFR decreases. THЕ AIM: to study the occurrence of hypothyroidism in patients with different stages of CKD, to evaluate the parameters of thyroid status and antithyroid antibodies in patients with CKD. PATIENTS AND METHODS. 953 patients from I.P. Pavlov SPbSMU clinics (screening group) were examined. TSH, free T4, serum creatinine were defined and eGFR was calculated using the formula CKD-EPI in all patients. A group of patients with hypothyroidism accounted for 466 patients. Patients with a normal TSH of 0.4-2.5 mIU / L (comparison group) were selected from the screening group. RESULTS. eGFR in the screening group and in the group of hypothyroid patients correlated with age. Hypothyroidism was associated with female sex and older age. In the group of patients with advanced stage CKD (3B-5), the incidence of subclinical and manifest hypothyroidism was 3 times higher than in the group with normal GFR (GFR> 90 ml / min, p = 0.007). In the group of patients with hypothyroidism, the frequency of advanced stages of CKD (3B-5) was 2 times higher than in the comparison group (p = 0.02). In patients with CKD, a direct correlation was found between GFR and free T3 (r = 0.34, p = 0.02). Thyroid peroxidase antibodies were revealed in 64% of patients with CKD with hypothyroidism. CONCLUSION. Hypothyroidism is associated with chronic kidney disease. For patients with CKD, there is a syndrome of euthyroid pathology ("low T3" syndrome). Hypothyroidism in patients with CKD is not always the outcome of autoimmune thyroiditis.

1. Rhee CM, Kalantar-Zadeh K, Streja E et al. The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease. Nephrol Dial Transplant 2015; 30: 282–287. Doi: 10.1093/ndt/gfu303

2. Chuang M-H, Liao K-M, Hung Y-M et al. Abnormal ThyroidStimulating Hormone and Chronic Kidney Disease in Elderly Adults in Taipei City. J Am Geriatr Soc 2016; 64: 1267–1273. Doi: 10.1111/jgs.14102

3. Lee DY, Jee JH, Jun JE et al. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects. Endocrine 2017; 55: 503–512. Doi: 10.1007/s12020-016-1138-8

4. Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract 2016; 35: 165–168. Doi: 10.1016/j.krcp.2016.06.003

5. Chonchol M, Lippi G, Salvagno G et al. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1296–1300. Doi: 10.2215/CJN.00800208

6. Lo JC, Chertow GM, Go AS et al. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005; 67: 1047–1052. Doi: 10.1111/j.1523-1755.2005.00169.x

7. Schultheiss UT, Daya N, Grams ME et al. Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study. Nephrol Dial Transplant 2017; 32: 1874–1881. Doi: 10.1093/ndt/gfw301

8. Rhee CM, Ravel VA, Streja E et al. Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort. J Clin Endocrinol Metab 2016; 101: 4054–4061. Doi: 10.1210/ jc.2016-1691

9. Gardner DF, Mars DR, Thomas RG et al. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 7: 471–476

10. Sato K, Okamura K, Yoshinari M et al. Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol (Copenh) 1992; 126: 253–259

11. Кеттайл ВМ, Арки РА. Патофизиология эндокринной системы. BINOM Publishers 2001 [Kettai`l VM, Arki RA. Patofiziologiia e`ndokrinnoi` sistemy`. BINOM Publishers 2001]

12. Lim VS, Fang VS, Katz AI et al. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 1977; 60: 522–534. Doi:10.1172/JCI108804

13. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the ‘euthyroid sick syndrome’. Endocr Rev 1982; 3: 164–217. Doi: 10.1210/edrv-3-2-164

14. Barlet C, Doucet A. Lack of stimulation of kidney Na-KATPase by thyroid hormones in long-term thyroidectomized rabbits. Pflugers Arch 1986; 407: 428–431

15. Suher M, Koc E, Ata N et al. Relation of thyroid disfunction, thyroid autoantibodies, and renal function. Ren Fail 2005; 27: 739–742

16. Michael UF, Barenberg RL, Chavez R et al. Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies. J Clin Invest 1972; 51: 1405–1412. Doi: 10.1172/JCI106936

17. Hanna FW, Scanlon MF. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet (London, England) 1997; 350: 755–756. Doi: 10.1016/S0140-6736(05)62563-9

18. Смирнов АВ, Шилов ЕМ, Добронравов ВА и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Клиническая нефрология 2012; 4: 4–26 [Smirnov AV, Shilov EM, Dobronravov VA et al. Natcional`ny`e rekomendatcii. Khronicheskaia bolezn` pochek: osnovny`e printcipy` skrininga, diagnostiki, profilaktiki i podhody` k lecheniiu. Clinicheskaia nefrologiia 2012; 4: 4–26]

19. Фадеев ВВ. По материалам клинических рекомендаций Американской ассоциации клинических эндокринологов и Американской тиреоидной ассоциации по диагностике и лечению гипотиреоза у взрослых. Клиническая и экспериментальная тиреоидология 2012; 8: 9–16. Doi: 10.4158/EP12280. GL [Fadeev VV. Po materialam clinicheskikh rekomendatcii` Amerikanskoi` assotciatcii clinicheskikh e`ndokrinologov i Amerikanskoi` tireoidnoi` assotciatcii po diagnostike i lecheniiu gipotireoza u vzrosly`kh. Clinicheskaia i e`ks perimental`naia tireoidologiia 2012; 8: 9–16. Doi: 10.4158/EP12280.GL]

20. Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55–68

21. Hak AE, Pols HA, Visser TJ et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132: 270–278

22. Faber J, Heaf J, Kirkegaard C et al. Simultaneous turnover studies of thyroxine, 3,5,3’ and 3,3’,5’-triiodothyronine, 3,5-, 3,3’-, and 3’,5’- diiodothyronine, and 3’-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 1983; 56: 211–217. Doi: 10.1210/jcem-56-2-211

23. Kaptein EM, Quion-Verde H, Chooljian CJ et al. The thyroid in end-stage renal disease. Medicine (Baltimore) 1988; 67: 187–197